Evaluation of Mechanical Power and Ventilator Parameters to Predict Weaning Success in the Intensive Care Unit
NCT ID: NCT07268989
Last Updated: 2025-12-12
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
RECRUITING
60 participants
OBSERVATIONAL
2025-07-01
2026-07-01
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Can the mechanical power (MP) value predict successful extubation? Do other respiratory parameters-airway occlusion pressure (P0.1), negative inspiratory force (NIF), and the rapid shallow breathing index (RSBI)-provide additional prognostic value for weaning outcomes?
Participants will:
* Be adult ICU patients planned for weaning from mechanical ventilation.
* Undergo bedside ventilatory assessment within 2 hours after meeting clinical weaning criteria.
* Have the following respiratory parameters measured: MP, P0.1, NIF, and RSBI.
* Be monitored for 48 hours after extubation to assess weaning success (defined as no need for reintubation, non-invasive ventilation, or high-flow oxygen support)
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Assessment of Ventilation Parameters for Extubation Prediction in ICU
NCT06531005
Can Total Mechanical Power Be a Determinant of Weaning Failure in Chronic Obstructive Pulmonary Disease (COPD)?
NCT06751654
Mechanical Power As a Predictor for Weaning in Chronic Obstructive Pulmonary Disease Patients :Prospective Cohort Study.
NCT06493929
Effect of Increased Muscular Work During Different Weaning Strategies in Critically Ill Patients
NCT00538746
The Effect of the Position Given to the Child After Weaning from Noninvasive Mechanical Ventilation on Physiological Symptoms
NCT06580522
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Secondary objectives include the evaluation of additional respiratory parameters such as airway occlusion pressure (P0.1), negative inspiratory force (NIF), the rapid shallow breathing index (RSBI), and the mechanical power/negative inspiratory force ratio (MP/NIF). These parameters will be measured at the bedside within 2 hours after patients meet clinical weaning criteria and are hemodynamically stable.
All participants will be monitored for 48 hours after extubation. Weaning success is defined as the ability to sustain spontaneous breathing without the need for reintubation, non-invasive ventilation, or high-flow oxygen therapy during this period.
Data collection will include:
Respiratory measurements obtained from the ventilator: MP, P0.1, NIF, RSBI, and MP/NIF.
Demographic and clinical data: age, sex, BMI, ICU admission diagnosis, APACHE II and SOFA scores, ventilator settings, and duration of mechanical ventilation.
Post-extubation follow-up: reintubation, non-invasive ventilation or high-flow oxygen use, SpO₂ values, blood gas analysis, and vital signs.
This study does not involve any interventions beyond standard ICU care. Ventilator-based respiratory assessments are routinely performed in ICU settings and pose no additional risk to participants.
The results may support the integration of load-drive-capacity assessment into routine ICU weaning protocols and improve clinical decision-making by reducing the incidence of weaning failure and associated complications.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
COHORT
PROSPECTIVE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Mechanically Ventilated ICU Patients Undergoing Weaning
Adult patients receiving mechanical ventilation in the intensive care unit (ICU) who meet clinical criteria for planned weaning and extubation. All patients will undergo bedside ventilator-based respiratory assessment to evaluate mechanical power (MP), airway occlusion pressure (P0.1), negative inspiratory force (NIF), and the rapid shallow breathing index (RSBI) prior to extubation.
Mechanical power
Non-invasive bedside evaluation of respiratory load, neural drive, and inspiratory muscle capacity using mechanical power (MP), airway occlusion pressure (P0.1), negative inspiratory force (NIF), and the rapid shallow breathing index (RSBI).
• Measurements will be performed once within 2 hours prior to the extubation decision as part of routine ICU respiratory monitoring.
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Mechanical power
Non-invasive bedside evaluation of respiratory load, neural drive, and inspiratory muscle capacity using mechanical power (MP), airway occlusion pressure (P0.1), negative inspiratory force (NIF), and the rapid shallow breathing index (RSBI).
• Measurements will be performed once within 2 hours prior to the extubation decision as part of routine ICU respiratory monitoring.
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
Age ≥ 18 years (adult patient population)
* Patients receiving invasive mechanical ventilation in the intensive care unit
* Having been intubated for at least 24 hours
* Patients for whom the clinical team has decided extubation and who meet the following weaning criteria:
* Stable respiratory parameters (FiO₂ ≤ 40%, PEEP ≤ 5 cmH₂O, SpO₂ ≥ 92%)
* Hemodynamic stability (no inotropic support or minimal/stable dose)
* Appropriate neurological status (able to follow commands)
* Stable acid-base balance
* Adequate secretion control
* Technically suitable ventilator and measurement conditions
* Written informed consent obtained from the patient or legal representative
Exclusion Criteria
and
* Individuals under 18 years of age
* Pregnant patients
* Patients who do not meet the weaning criteria
* Tracheostomized patients
* Neuromuscular diseases (e.g., Guillain-Barré syndrome, Duchenne muscular dystrophy, etc.)
* Technical inadequacy preventing correct ventilator measurements
* Significant asynchrony (e.g., auto-PEEP, double triggering, ineffective triggering, cycle asynchrony, auto-triggering)
* Patients without an extubation plan or those receiving palliative care
* RASS ≤ -2 (excessive sedation) for PSV mode measurements
* RASS ≥ +2 (agitation) for PSV-CPAP mode measurements
* Patients with delirium for PSV-CPAP mode measurements
* Patients who cannot provide consent, have no legal representative, or whose representative refuses consent
18 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Anıl Berkay Balıtatlı
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Anıl Berkay Balıtatlı
Resident Physician (Anesthesiology and Intensive Care)
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Health Science University İstanbul Kanuni Sultan Süleyman Education and Training Hospital
Istanbul, , Turkey (Türkiye)
Countries
Review the countries where the study has at least one active or historical site.
Central Contacts
Reach out to these primary contacts for questions about participation or study logistics.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
Mechanical Power
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.